Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).
about
The PD-1 pathway in tolerance and autoimmunityPD-L1 expression in human cancers and its association with clinical outcomesThe efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysisPD-1/PD-L1 blockades in non-small-cell lung cancer therapyAdaptive Immune Resistance: How Cancer Protects from Immune AttackNew immunotherapies targeting the PD-1 pathwayThe PD1:PD-L1/2 Pathway from Discovery to Clinical ImplementationControl of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection.PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer.The antitumor activity and preliminary modeling on the potential mechanism of action of human peroxiredoxin-5.At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.Interferons and their stimulated genes in the tumor microenvironmentIRF7 regulates TLR2-mediated activation of splenic CD11c(hi) dendritic cells.Immune sculpting of norepinephrine on MHC-I, B7-1, IDO and B7-H1 expression and regulation of proliferation and invasion in pancreatic carcinoma cellsT cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals.EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantationPD-L1 expression is increased in a subset of basal type breast cancer cells.Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism.Expression of PD-L1 on canine tumor cells and enhancement of IFN-γ production from tumor-infiltrating cells by PD-L1 blockadeKupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactionsInducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation.Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80RAS-Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers.Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell inductionInterferon- γ triggers hepatic stellate cell-mediated immune regulation through MEK/ERK signaling pathwayAt the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapyOncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1.Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusionThe complex role of B7 molecules in tumor immunology
P2860
Q24633549-282B1762-8899-4536-93DD-5D29C3172748Q26738361-1ED77968-907A-4E0B-A3F7-6EA2621B14CCQ26740280-E4825014-1102-429C-9849-268A020C887DQ26765024-64826DE8-3076-4B4B-AC68-7A91447D6EECQ26798448-A365948E-75D7-4DFC-B3AD-F276497D9C5DQ27010018-1783D7C9-3C90-4C82-8CDA-2D4EE2269EE2Q28066941-176D4CCC-9BB4-421C-9FCA-45B9D27A91C5Q30301182-2030F294-C221-4CAB-9F85-E34F34245E40Q33569771-98B00BC1-33CF-4C32-9B7D-2E9D3CAD4DA9Q33632062-A8EC2035-8F19-4040-907E-470DCE3207CCQ33648621-5881B8C9-725D-4A58-B874-1C527728E683Q33688982-5AB98309-8886-4E30-A98E-400CCA93A874Q33732329-104790BD-0420-456C-BBBD-07D0BD0237ABQ33763266-E6FB7224-B2FD-4961-905E-1523C381088AQ33788049-B7CE5477-8D81-4F80-AF8D-7704612EFFBFQ33988567-6B012E36-95F0-424E-B5F0-EFAC46C51CC6Q34345575-78FD4563-27B5-4F06-BC5B-C57E6DA7B31CQ34429197-E13CFD2D-3BC2-4C58-ACAC-3F40D6B5F6E5Q34577158-4FF90274-3531-4753-A9C4-2C89D5D3C8A0Q34661815-4634770E-E712-453C-AA18-801BBC6D1C49Q34707439-87F5482E-B7D7-4A3C-B57D-EBDA79A5610FQ35067875-5B4D71EA-5BDF-4F07-9E9C-59D1F7D262E2Q35074541-D23F67E4-4DA8-43A9-A229-F8FFDD952A6CQ35097436-DC413F9E-D71E-4922-B677-867ACAEF8084Q35151883-4D7B37EA-3288-4EDD-ACF0-09BBFCC4FA7AQ35184110-67638532-8202-417C-91DD-AA6A657E567AQ35184928-8469F433-5F91-4E8D-A1EA-374B8CBD33C2Q35422283-EC07A271-2708-462F-B118-3FAF1C38AA77Q35681604-37310C3C-DC51-4AE7-8B73-BBB1A6639182Q35713265-D6106AF5-6DBA-40B7-955F-041C8336EF24Q36039709-C24E479D-72A3-47BA-89F4-9A2AC7B86982Q36193035-72E06DA8-1FC5-487F-B13B-5087189C5414Q36642668-0A1B6096-5188-442C-A218-929B673409A5Q36814620-11EAA499-BE2A-412D-B1D6-AEE62E67BFDFQ36869566-03F1A29E-8C05-4CA5-B1BF-5AC1CAD96A50Q36935749-96F3518F-AACE-4D7A-A787-C16560482357Q37081609-AF0D1E39-3F61-45A7-B848-F84982F1E3BFQ37202267-7CBD2F50-5C6B-4B72-8779-3EECC8964191Q37287632-FABDD9EC-884B-4D2C-8372-15252F3CD91FQ37304913-8C9684D4-42ED-4840-A2F7-342CAAF4CB0B
P2860
Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interferon regulatory factor-1 ...... upregulation of B7-H1 (CD274).
@ast
Interferon regulatory factor-1 ...... upregulation of B7-H1 (CD274).
@en
Interferon regulatory factor-1 ...... -induced upregulation of B7-H1
@nl
type
label
Interferon regulatory factor-1 ...... upregulation of B7-H1 (CD274).
@ast
Interferon regulatory factor-1 ...... upregulation of B7-H1 (CD274).
@en
Interferon regulatory factor-1 ...... -induced upregulation of B7-H1
@nl
prefLabel
Interferon regulatory factor-1 ...... upregulation of B7-H1 (CD274).
@ast
Interferon regulatory factor-1 ...... upregulation of B7-H1 (CD274).
@en
Interferon regulatory factor-1 ...... -induced upregulation of B7-H1
@nl
P2093
P2860
P1433
P1476
Interferon regulatory factor-1 ...... upregulation of B7-H1 (CD274).
@en
P2093
Byeong-Churl Jang
In-Hak Choi
Jae-Gook Shin
Lieping Chen
Sangtaek Oh
Seong-Il Suh
Seung-Jin Lee
Soo-Woong Lee
Yeong-Min Park
P2860
P304
P356
10.1016/J.FEBSLET.2005.12.093
P407
P577
2006-01-09T00:00:00Z